<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский кардиологический журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2020-4023</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-4023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Contribution of electrocardiography to the diagnosis of cardiomyopathies and athletic heart syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Место электрокардиографии в диагностике кардиомиопатий и спортивного сердца</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2373-1183</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чумакова</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Chumakova</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доцент кафедры терапии, кардиологии и функцональной диагностики с курсом нефрологии, к.м.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>professor's assistant at the scientific department of internal medicine, cardiology and functional diagnostics with nephrological course, PhD</p><p>Moscow</p></bio><email xlink:type="simple">chumakovaolga@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3548-9937</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Исаева</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Isaeva</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-кардиолог, к.м.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Cardiologist, PhD</p><p>Moscow</p></bio><email xlink:type="simple">maris_07@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5646-796X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королева</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Koroleva</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассисент кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии, к.м.н.</p><p>Москва</p></bio><bio xml:lang="en"><p>Assistant at the scientific department of internal medicine, cardiology and functional diagnostics with nephrological course, PhD</p><p>Moscow</p></bio><email xlink:type="simple">olgakoroleva@hotmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7065-2045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Затейщиков</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zateyshchikov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. кафедрой терапии, кардиологии и функциональной диагностики с курсом нефрологии, д.м.н., профессор </p><p>Москва</p></bio><bio xml:lang="en"><p>Head of the scientific department of internal medicine, cardiology and functional diagnostics with nephrological course, PhD, DMS, Professor</p><p>Moscow</p></bio><email xlink:type="simple">dz@bk.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» УД Президента РФ; ФГБУ «ФНКЦ специализированных видов медицинской помощи и медицинских технологий ФМБА России»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy, Administrative Directorate of the President of the Russian Federation; Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «ФНКЦ специализированных видов медицинской помощи и медицинских технологий ФМБА России»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» УД Президента РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy, Administrative Directorate of the President of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» УД Президента РФ; ФГБУ «ФНКЦ специализированных видов медицинской помощи и медицинских технологий ФМБА России»; ГБУЗ «Городская клиническая больница №51 ДЗ г. Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central state medical academy of the department of Presidential affairs; Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia; City Clinical Hospital No 51</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>07</month><year>2020</year></pub-date><volume>25</volume><issue>3S</issue><issue-title>S3</issue-title><fpage>4023</fpage><lpage>4023</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Chumakova O.S., Isaeva M.Y., Koroleva O.S., Zateyshchikov D.A., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Чумакова О.С., Исаева М.Ю., Королева О.С., Затейщиков Д.А.</copyright-holder><copyright-holder xml:lang="en">Chumakova O.S., Isaeva M.Y., Koroleva O.S., Zateyshchikov D.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/4023">https://russjcardiol.elpub.ru/jour/article/view/4023</self-uri><abstract><p>The review describes the role of electrocardiography in the diagnosis of the most common nonischemic myocardial diseases associated with an increased risk of sudden cardiac death, especially in youth sports.</p></abstract><trans-abstract xml:lang="ru"/><kwd-group xml:lang="ru"><kwd>электрокардиография</kwd><kwd>кардиомиопатии</kwd><kwd>спортивное сердце</kwd><kwd>внезапная смерть</kwd></kwd-group><kwd-group xml:lang="en"><kwd>electrocardiography</kwd><kwd>cardiomyopathies</kwd><kwd>athlete heart</kwd><kwd>sudden death</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках гранта Российского научного фонда (№ 20-15-00353).</funding-statement><funding-statement xml:lang="en">This study was carried out within the grant from the Russian Science Foundation (№ 20-15-00353).</funding-statement></funding-group></article-meta></front><body><p>Electrocardiography (ECG) is the most accessible and reproducible method for cardiac assessment. For a long time, in nonischemic myocardial diseases, abnormalities in the ECG were considered nonspe­cific. Recent studies with modern technologies, such as magnetic resonance imaging (MRI) and genetic testing, have made significant progress in under­standing pathological processes in the myocardium and defining specific ECG abnormalities for some of them. In cardiomyopathies, ECG abnormalities observed in coronary artery disease and hypertension (HTN) have a different origin and are due to micro­circulation disorders, interstitial fibrosis, disorga­nized cardiomyocytes or their fibro-fatty replace­ment, as well as asymmetric hypertrophy, changing the QRS axis. The correct interpretation of ECG abnormalities often allows one to promptly assume the true nature of the disease. In some cases, ECG abnormalities are the only phenotypic manifesta­tion of inherited heart disease [<xref ref-type="bibr" rid="cit1">1</xref>], which makes the method indispensable for family screening.</p><p>In athletes, more often in dynamic sports (cycling, football, running), long-term intense exercise leads to structural and electrical adaptive changes, which are commonly called the “athletic heart syndrome” [<xref ref-type="bibr" rid="cit2">2</xref>]. These changes are benign in most cases, but sometimes they can lead to cardiomyopathies, which are the leading cause of sudden cardiac death (SCD) in young athletes [<xref ref-type="bibr" rid="cit3">3</xref>]. The correct interpretation of the ECG in athletes, on the one hand, can help to timely diagnose a fatal disease, and on the other hand, to avoid false disqualification [<xref ref-type="bibr" rid="cit3">3</xref>][<xref ref-type="bibr" rid="cit4">4</xref>].</p><sec><title>Arrhythmogenic cardiomyopathy</title><p>Arrhythmogenic cardiomyopathy (ACM), previ­ously defined only as a arrhythmogenic right ven­tricular (RV) dysplasia, is a genetic disease of the myocardium of RV and/or left ventricle (LV). The distinctive phenotypic feature of ACM is the scarring in the form of fibrous or fibro-fatty replacement of cardiomyocytes which serve as a substrate for global and/or local myocardial dysfunction and predispose to fatal ventricular arrhythmias [<xref ref-type="bibr" rid="cit5">5</xref>]. The diagnosis of ACM is collective and is based on a combination of morphological, functional, and structural myocar­dial changes, revealed by echocardiography, MRI, biopsy, resting ECG, and 24-hour ambulatory ECG monitoring. Analysis of family history and genetic testing also plays an important role in the diagnosis of ACM.</p><p>On the ECG of ACM patients, there are cri­teria specific for the predominant involvement of the RV or LV, which are subdivided into major and minor [<xref ref-type="bibr" rid="cit5">5</xref>]. Thus, inverted T-waves in the right-sided chest leads (V1-V3) in adults without complete right bundle branch block (RBBB) is a major criterion for right-dominant ACM. The spread of inverted T-waves to V4-V6 indicates significant RV dilata­tion and dysfunction (Figure 1). In the case of com­plete RBBB, such inversions become less specific and refer to the minor criteria of right-dominant ACM. Also, diseases that may resemble ACM should always be ruled out, such as heart displacement due to pericardiotomy or chest wall deformity, RV vol­ume or pressure overload, cardiac sarcoidosis, and myocarditis [<xref ref-type="bibr" rid="cit6">6</xref>].</p><fig id="fig-1"><caption><p>Figure 1. The 42-year-old female patient with biventricular ACM and dominated LV involvement. A. ECG: low QRS voltage in limb leads and inverted T wave in V1-V6; frequent premature ventricular contractions with a configuration of complete LBBB and the superior axis. B. MRI: biventricular dilatation, LV NCM.</p></caption><graphic xlink:href="russjcardiol-25-3S-g001.png"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/russjcardiol/2020/3s3/D7SeP8WMLux1BaIiFsdF3Vwv5TaRynj7xqev4dv0.png</uri></graphic></fig><p>Epsilon wave, previously referred to major ACM criteria, is a reproducible low-amplitude signal between the QRS end and T-wave beginning. Over the past ten years, the diagnostic value of this crite­rion has been questioned due to its various interpretation [<xref ref-type="bibr" rid="cit7">7</xref>], and in the 2020 updated Padua criteria [<xref ref-type="bibr" rid="cit5">5</xref>], the epsilon wave is attributed to the minor cri­terion of right-dominant ACM, as well as terminal activation duration &gt;55 ms, measured from the nadir of the S wave to the end of the QRS, including R’, in V1, V2, or V3 (in the absence of complete RBBB).</p><p>Low QRS voltage in limb leads (&lt;5 mm) may indicate LV involvement in ACM (Figure 1). The sensitivity of this criterion is low (&lt;30%); therefore, it is considered minor for the left-dominant ACM in the absence of obesity, emphysema, or pericardial effusion [<xref ref-type="bibr" rid="cit5">5</xref>]. Also, minor criteria for left-dominant ACM include inverted T waves in left precordial leads (in the absence of complete left bundle branch block (LBBB)) [<xref ref-type="bibr" rid="cit5">5</xref>]. The isolated left-dominant ACM is phenotypically indistinguishable from dilated car­diomyopathy (DCM) and is often confirmed only by genetic testing.</p><p>Registration of late potentials using a signal-ave­raged ECG has not found wide application in prac­tice and is no longer used for the diagnosis of ACM.</p><p>Ventricular arrhythmia with a configuration of complete LBBB and the inferior axis, which indi­cates its origin from the RV outflow tract is a minor criterion, and without the lower axis, it is a major criterion for right-dominant ACM [<xref ref-type="bibr" rid="cit5">5</xref>] (Figure 1). Ventricular arrhythmia with a configuration of com­plete RBBB is a minor criterion for left-dominant ACM [<xref ref-type="bibr" rid="cit5">5</xref>].</p><p>Myocardial changes similar to ACM, such as sig­nificant RV enlargement, borderline decrease in the RV ejection fraction (EF), and ventricular arrhyth­mias, can be induced by regular exercises in healthy individuals [<xref ref-type="bibr" rid="cit8">8</xref>][<xref ref-type="bibr" rid="cit9">9</xref>]. The physiological RV changes on the ECG include voltage criteria for RV hypertrophy, isolated complete RBBB, and right axis deviation Highly sensitive to ACM inversed T-wave, in the right-sided chest leads loses its specificity in athletes due to a fairly high prevalence (up to 4% in V1-V3 and 10% in V1-V2) [<xref ref-type="bibr" rid="cit2">2</xref>]. According to our unpub­lished data based on the analysis of 619 ECG records of athletes, inversed T-waves in V1-V3 without any significant structural changes in the heart occur in 1,9% of cases (Figure 2). Nevertheless, today in white athletes, any inversed T-waves in two contiguous leads, including in V1-V3, is regarded as pathological and requires in-depth examination and follow-up. In black athletes, such inversions, especially with ST- segment elevation and a J-point &gt;1 mm, are referred to as benign [<xref ref-type="bibr" rid="cit10">10</xref>]. In addition to inversed T-waves, ACM can be suspected in athletes when recording ventricular arrhythmias and epsilon waves.</p><fig id="fig-2"><caption><p>Figure 2. A. The 24-year-old male athlete, pentathlon, asymptomatic. Echocardiography, cardiac MRI, 24-hour ECG monitoring did not reveal any pathology. ECG: inverted T-wave in V1-V3 with preceding ST elevation at J-point &gt;1 mm. B. The 35-year-old female athlete, cycling, asymptomatic, without structural heart disease. ECG: inverted T wave in V1-V3, isolated increase in QRS voltage.</p></caption><graphic xlink:href="russjcardiol-25-3S-g002.png"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/russjcardiol/2020/3s3/4c6FBIc03B0l6luVtyG3NDI4bqdpvLjA2wyEemvr.png</uri></graphic></fig></sec><sec><title>LV hypertrophy</title><p>Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. In 60% of patients, HCM is caused by sarcomere gene muta­tions. In 5-10%, HCM is simulated by rare storage diseases (Fabry, Danon, PRKAG2 cardiomyopa­thy), infiltrative diseases (amyloidosis, sarcoidosis), mitochondrial, neuromuscular diseases (Friedreich’s ataxia), malformations (Noonan syndrome), and endocrine cardiomyopathies. In the remaining 30% of patients, the cause of HCM has not yet been clarified [<xref ref-type="bibr" rid="cit11">11</xref>]. Unlike ACM, the criteria for the HCM diagnosis are only morphological: LV myo­cardial thickening in adults &gt;15 mm (&gt;13 mm in the presence of a relative with HCM), which cannot be explained by other conditions leading to LV overload (HTN, aortic valve stenosis) [<xref ref-type="bibr" rid="cit12">12</xref>].</p><p>ECG abnormalities, mainly inversed T-waves or deep narrow (“dagger-like”) Q waves with a positive T wave in the inferior and lateral leads, are recorded in more than 90% of patients with sarcomeric HCM [<xref ref-type="bibr" rid="cit13">13</xref>]. “Giant” (&gt;10 mm) symmetric T waves, usually present in all chest leads, indicate severe hypertro­phy of the LV apex [<xref ref-type="bibr" rid="cit14">14</xref>] (Figure 3). Pseudo-infarct QS complexes in the chest leads and complete bun­dle branch blocks occur infrequently in HCM and mainly after surgical reduction of the interventricular septum or in severe transmural fibrosis [<xref ref-type="bibr" rid="cit13">13</xref>]. Such changes are more typical for infiltrative diseases [<xref ref-type="bibr" rid="cit15">15</xref>][<xref ref-type="bibr" rid="cit16">16</xref>] (Figure 4).</p><fig id="fig-3"><caption><p>Figure 3. The 34-year-old male patient with the apical familial HCM. A. ECG: “giant” inverted T-waves in V2-V6, LV hypertrophy voltage signs. B. Echocardiography: hypertrophy of LV apex with ace-of-spades sign.</p></caption><graphic xlink:href="russjcardiol-25-3S-g003.png"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/russjcardiol/2020/3s3/IujJEsdXex9YuTzk9GZFRL6N9y57MYZwJAv7qd2u.png</uri></graphic></fig><p> </p><p> </p><fig id="fig-4"><caption><p>Figure 4. The 64-year-old female patient with familial transthyretin amyloidosis of the heart. A. ECG: low QRS voltage in limb leads and “normal”, not corresponding to the hypertrophy severity on echocardiography, in the chest leads; R regression in V1-V4. B. Echocardiography: severe LV hypertrophy, atrial dilatation. C. Doppler echocardiography: a restrictive LV diastolic dysfunction.</p></caption><graphic xlink:href="russjcardiol-25-3S-g004.png"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/russjcardiol/2020/3s3/Ig6SzZVad43Z0FTjfZtVWqKf6zvZQVc7QxUuEi0B.png</uri></graphic></fig><p>The combination of visually severe LV hypertro­phy with conduction abnormalities on the ECG is always suspicious for HCM phenocopies. Thus, a shortened PQ interval should be suggestive of storage [<xref ref-type="bibr" rid="cit17">17</xref>] or mitochondrial diseases [<xref ref-type="bibr" rid="cit1">1</xref>], while an atrioven­tricular conduction delay suggests amyloidosis [<xref ref-type="bibr" rid="cit15">15</xref>], sarcoidosis [<xref ref-type="bibr" rid="cit16">16</xref>], or end-stage storage and mitochon­drial diseases [<xref ref-type="bibr" rid="cit1">1</xref>][<xref ref-type="bibr" rid="cit13">13</xref>][<xref ref-type="bibr" rid="cit17">17</xref>].</p><p>In many patients with HCM, voltage criteria for LV hypertrophy are recorded, and only in 2% they are not accompanied by impaired repolarization [<xref ref-type="bibr" rid="cit18">18</xref>]. If the voltage is very high, then it is worth suspecting the storage disease [<xref ref-type="bibr" rid="cit13">13</xref>]. If, on the contrary, the QRS voltage is reduced or normal with severe hypertrophy on ECG, then amyloidosis should be suspected [<xref ref-type="bibr" rid="cit15">15</xref>] (Figure 4).</p><p>Every eighth patient with HCM has elongated QT interval &gt;480 ms, and every second patient has &gt;450 ms, which is associated with the risk of SCD and is an additional argument for implantation of a cardioverter-defibrillator [<xref ref-type="bibr" rid="cit13">13</xref>][<xref ref-type="bibr" rid="cit19">19</xref>].</p><p>About 5-10% of patients with HCM phenotype have either a normal ECG or an isolated increase in QRS voltage. In such patients, the disease debuts later, the symptoms are less pronounced and the prognosis is better [<xref ref-type="bibr" rid="cit13">13</xref>][<xref ref-type="bibr" rid="cit20">20</xref>].</p><p>Physiological hypertrophy in athletes does not exceed 14 mm in men [<xref ref-type="bibr" rid="cit21">21</xref>] and 12 mm in women [<xref ref-type="bibr" rid="cit22">22</xref>]; nevertheless, it is always suspicious of the HCM onset. One of the most characte­ristic ECG signs of an athlete’s heart is a pro­nounced increase in QRS voltage, which is often mistakenly considered as LV hypertrophy. Unlike pathological hypertrophy, there are no concomi­tant repolarization abnormalities on an athlete’s ECG, therefore, a moderate LV wall thickening on echocardiography in combination with an iso­lated increase in QRS voltage indicates physio­logical myocardial remodeling. Repolarization disorders in the form of inverted T wave &gt;1 mm in more than 2 contiguous inferior (II and aVF) and, especially, lateral (I, aVL, V5 or V6) leads indicate a possible HCM [<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>Inverted T wave in the inferior and lateral leads are recorded on the ECG of athletes with­out structural cardiac changes. Isolated T wave inversions in the inferior leads are found in 2% of white and 6% of healthy black athletes [<xref ref-type="bibr" rid="cit13">13</xref>], which is much more frequent than inherited heart diseases. According to our unpublished data with 1435 ECGs of athletes from various sports, iso­lated T wave inversions in the inferior leads are found in 1% of cases. Inverted T waves in the lateral leads are considered the most unfavorable, since they may be the first sign of cardiomyopathy [<xref ref-type="bibr" rid="cit23">23</xref>]. Abnormalities suspicious of HCM in athletes also include pathological Q waves (&gt;0,25 from the R wave or &gt;40 ms), ST depression &gt;0,5 mm in &gt;2 contiguous leads, complete LBBB, non-specific prolonged QRS &gt;140 ms, and frequent premature ventricular contractions [<xref ref-type="bibr" rid="cit4">4</xref>].</p></sec><sec><title>LV systolic dysfunction</title><p>Dilated cardiomyopathy (DCM) is a syndrome characterized by systolic dysfunction and LV dilata­tion, which cannot be explained by coronary artery disease or conditions leading to LV overload (HTN, valvular and congenital heart disease). LV systolic dysfunction (LVEF &lt;45%) without dilatation since 2016 has been classified as hypokinetic non-dilated cardiomyopathy [<xref ref-type="bibr" rid="cit24">24</xref>].</p><p>DCM is the most etiologically heterogeneous cardiomyopathy. About 40% of DCM cases are inherited [<xref ref-type="bibr" rid="cit25">25</xref>], which can manifest as isolated heart disease, in combination with conduction defects and noncompacted myocardium (NCM), or within the systemic muscle diseases. Among the latter, the most common DCM phenotype occurs in muscular dystrophies (Duchenne and Becker), limb-girdle muscular dystrophies (LGMD), and Emery-Dreifuss muscular dystrophy (EDMD) [<xref ref-type="bibr" rid="cit26">26</xref>]. Familial DCM occurs due to mutations in the genes of sarcomere (titin), cytoskeleton (dys­trophin, desmin), cell membranes (lamin, ion channels), and organelles [<xref ref-type="bibr" rid="cit25">25</xref>]. Acquired DCMs develop due to infections, autoimmune diseases, toxic (alcohol, cocaine) or medication (chemo­therapy) myocardial damage, micronutrient defi­ciencies, endocrine and metabolic diseases, and pregnancy [<xref ref-type="bibr" rid="cit24">24</xref>]. Separately, authors distinguish tachycardia-induced cardiomyopathy — a poten­tially reversible decrease in LV systolic function, which develops with permanent atrial or ven­tricular tachyarrhythmia [<xref ref-type="bibr" rid="cit27">27</xref>]. There is evidence that patients with non-familial DCM also have a genetic substrate of the disease [<xref ref-type="bibr" rid="cit25">25</xref>][<xref ref-type="bibr" rid="cit28">28</xref>][<xref ref-type="bibr" rid="cit29">29</xref>][<xref ref-type="bibr" rid="cit30">30</xref>].</p><p> </p><p> 

Table 1
Specific signs of cardiomyopathies on resting ECG




Phenotype


ECG abnormalities Suggested diagnosis




Dilatation/impaired RV contractility


inverted T in V1-V3


major criterion of right-dominant ACM




inverted T in V1-V4(V6)


significant RV involvement




ε-wave in V1-V2


minor criterion of right-dominant ACM




TAD &gt;55 ms in V1-V3


minor criterion of right-dominant ACM




↓ QRS in limb leads


biventricular ACM




inverted T inV4-V6/I, aVL


biventricular ACM




LV hypertrophy


shortened PQ


Fabry, Danon, Pompe, PRKAG2, mitochondrial diseases




AV blocks


amyloidosis, end-stage Fabry, Danon, acute myocarditis




↑↑ QRS voltage


Danon, Pompe




↓ or ’normal’ QRS voltage


amyloidosis




right QRS axis deviation


Noonan syndrome




LV systolic dysfunction


&gt; Р/atrial standstill


type 1 and 2 EDMD




sinus bradycardia


laminopathy




shortened PQ


DMD




AV blocks


sarcoidosis, laminopathy, EDMD, myotonic dystrophy, desminopathy, Chagas disease, diphtheria, Lyme disease




Q/QS in inferolateral leads


DMD, BMD, sarcoidosis, LGMD




↓ QRS


Left-dominant ACM




Complete RBBB


DMD, Chagas disease (+ left anterior fascicular block)




inverted T in V1-V6


Left-dominant and biventricular ACM




Hypertrabeculation of LV


Complete LBBB


NCM




pathological Q waves




inverted T




Abbreviations: ACM — arrhythmogenic cardiomyopathy, LV — left ventricle, LBB — left bundle branch, EDMD — Emery-Dreifuss muscular dystrophy, NCM — noncompacted myocardium, RV — right ventricle, LGMD — limb-girdle muscular dystrophies, BMD — Becker muscular dystrophy, DMD — Duchenne muscular dystrophy, TAD — terminal activation delay.

</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(19):1448-58. doi: 10.1093/eurheartj/ehs397.</mixed-citation><mixed-citation xml:lang="en">Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(19):1448-58. doi: 10.1093/eurheartj/ehs397.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Brosnan M, La Gerche A, Kalman J, et al. Comparison of frequency of significant electrocardiographic abnormalities in endurance versus nonendurance athletes. Am J Cardiol. 2014;113(9):1567-73. doi: 10.1016/j.amjcard.2014.01.438.</mixed-citation><mixed-citation xml:lang="en">Brosnan M, La Gerche A, Kalman J, et al. Comparison of frequency of significant electrocardiographic abnormalities in endurance versus nonendurance athletes. Am J Cardiol. 2014;113(9):1567-73. doi: 10.1016/j.amjcard.2014.01.438.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Corrado D, Basso C, Rizzoli G, et al. Does Sports Activity Enhance the Risk of Sudden Death in Adolescents and Young Adults? JACC. 2003;42(11):1959-63. doi: 10.1016/j.jacc.2003.03.002</mixed-citation><mixed-citation xml:lang="en">Corrado D, Basso C, Rizzoli G, et al. Does Sports Activity Enhance the Risk of Sudden Death in Adolescents and Young Adults? JACC. 2003;42(11):1959-63. doi: 10.1016/j.jacc.2003.03.002</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma S, Drezner JA, Baggish A, et al. International Recommendations for Electrocardiographic Interpretation in Athletes. J Am Coll Cardiol. 2017;69(8):1057-1075. doi: 10.1016/j.jacc.2017.01.015.</mixed-citation><mixed-citation xml:lang="en">Sharma S, Drezner JA, Baggish A, et al. International Recommendations for Electrocardiographic Interpretation in Athletes. J Am Coll Cardiol. 2017;69(8):1057-1075. doi: 10.1016/j.jacc.2017.01.015.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Corrado D, Marra MP, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020. doi: 10.1016/j.ijcard.2020.06.005.</mixed-citation><mixed-citation xml:lang="en">Corrado D, Marra MP, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020. doi: 10.1016/j.ijcard.2020.06.005.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Quarta G, Husain SI, Flett AS, et al. Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:16. doi: 10.1186/1532-429X-15-16.</mixed-citation><mixed-citation xml:lang="en">Quarta G, Husain SI, Flett AS, et al. Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:16. doi: 10.1186/1532-429X-15-16.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Platonov PG, Calkins H, Hauer RN, et al. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2016;13(1):208-16. doi: 10.1016/j.hrthm.2015.08.031.</mixed-citation><mixed-citation xml:lang="en">Platonov PG, Calkins H, Hauer RN, et al. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2016;13(1):208-16. doi: 10.1016/j.hrthm.2015.08.031.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">La Gerche A, Claessen G, Dymarkowski S, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015;36(30):1998-2010. doi: 10.1093/eurheartj/ehv202.</mixed-citation><mixed-citation xml:lang="en">La Gerche A, Claessen G, Dymarkowski S, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015;36(30):1998-2010. doi: 10.1093/eurheartj/ehv202.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zaidi A, Ghani S, Sharma R, et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation. 2013;127(17):1783-92. doi: 10.1161/CIRCULATIONAHA.112.000270.</mixed-citation><mixed-citation xml:lang="en">Zaidi A, Ghani S, Sharma R, et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation. 2013;127(17):1783-92. doi: 10.1161/CIRCULATIONAHA.112.000270.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Finocchiaro G, Papadakis M, Dhutia H, et al. Electrocardiographic differentiation between 'benign T-wave inversion' and arrhythmogenic right ventricular cardiomyopathy. Europace. 2019;21(2):332-338. doi: 10.1093/europace/euy179.</mixed-citation><mixed-citation xml:lang="en">Finocchiaro G, Papadakis M, Dhutia H, et al. Electrocardiographic differentiation between 'benign T-wave inversion' and arrhythmogenic right ventricular cardiomyopathy. Europace. 2019;21(2):332-338. doi: 10.1093/europace/euy179.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Seferovic PM, Polovina M, Bauersachs J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(5):553-576. doi: 10.1002/ejhf.1461.</mixed-citation><mixed-citation xml:lang="en">Seferovic PM, Polovina M, Bauersachs J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(5):553-576. doi: 10.1002/ejhf.1461.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35(39):2733-79. doi: 10.1093/eurheartj/ehu284.</mixed-citation><mixed-citation xml:lang="en">Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35(39):2733-79. doi: 10.1093/eurheartj/ehu284.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Finocchiaro G, Sheikh N, Biagini E, et al. The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart Rhythm. 2020;17(1):142-151. doi: 10.1016/j.hrthm.2019.07.019.</mixed-citation><mixed-citation xml:lang="en">Finocchiaro G, Sheikh N, Biagini E, et al. The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart Rhythm. 2020;17(1):142-151. doi: 10.1016/j.hrthm.2019.07.019.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dumont CA, Monserrat L, Soler R, et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J. 2006;27(14):1725-31. doi: 10.1093/eurheartj/ehl101.</mixed-citation><mixed-citation xml:lang="en">Dumont CA, Monserrat L, Soler R, et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J. 2006;27(14):1725-31. doi: 10.1093/eurheartj/ehl101.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bart NK, Thomas L, Korczyk D, et al. Amyloid Cardiomyopathy. Heart Lung Circ. 2020;29(4):575-583. doi: 10.1016/j.hlc.2019.11.019.</mixed-citation><mixed-citation xml:lang="en">Bart NK, Thomas L, Korczyk D, et al. Amyloid Cardiomyopathy. Heart Lung Circ. 2020;29(4):575-583. doi: 10.1016/j.hlc.2019.11.019.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Birnie DH, Nery PB, Ha AC, et al. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):411-21. doi: 10.1016/j.jacc.2016.03.605.</mixed-citation><mixed-citation xml:lang="en">Birnie DH, Nery PB, Ha AC, et al. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):411-21. doi: 10.1016/j.jacc.2016.03.605.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez-Sainz A, Dominguez F, Lopes LR, et al. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis. J Am Coll Cardiol. 2020;76(2):186-197. doi: 10.1016/j.jacc.2020.05.029.</mixed-citation><mixed-citation xml:lang="en">Lopez-Sainz A, Dominguez F, Lopes LR, et al. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis. J Am Coll Cardiol. 2020;76(2):186-197. doi: 10.1016/j.jacc.2020.05.029.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Calore C, Melacini P, Pelliccia A, et al. Prevalence and clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart: relevance to athletic screening. Int J Cardiol. 2013;168(4):4494-7. doi: 10.1016/j.ijcard.2013.06.123.</mixed-citation><mixed-citation xml:lang="en">Calore C, Melacini P, Pelliccia A, et al. Prevalence and clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart: relevance to athletic screening. Int J Cardiol. 2013;168(4):4494-7. doi: 10.1016/j.ijcard.2013.06.123.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Patel SI, Ackerman MJ, Shamoun FE, et al. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy. Acta Cardiol. 2019;74(1):53-58. doi: 10.1080/00015385.2018.1440905.</mixed-citation><mixed-citation xml:lang="en">Patel SI, Ackerman MJ, Shamoun FE, et al. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy. Acta Cardiol. 2019;74(1):53-58. doi: 10.1080/00015385.2018.1440905.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">McLeod CJ, Ackerman MJ, Nishimura RA, et al. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol. 2009;54(3):229-33. doi: 10.1016/j.jacc.2009.02.071.</mixed-citation><mixed-citation xml:lang="en">McLeod CJ, Ackerman MJ, Nishimura RA, et al. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol. 2009;54(3):229-33. doi: 10.1016/j.jacc.2009.02.071.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Abergel E, Chatellier G, Hagege AA, et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol. 2004;44(1):144-9. doi: 10.1016/j.jacc.2004.02.057.</mixed-citation><mixed-citation xml:lang="en">Abergel E, Chatellier G, Hagege AA, et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol. 2004;44(1):144-9. doi: 10.1016/j.jacc.2004.02.057.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pelliccia A, Maron BJ, Culasso F, et al. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA. 1996;276(3):211-5. doi: 10.1001/jama.276.3.211.</mixed-citation><mixed-citation xml:lang="en">Pelliccia A, Maron BJ, Culasso F, et al. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA. 1996;276(3):211-5. doi: 10.1001/jama.276.3.211.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358(2):152-61. doi: 10.1056/NEJMoa060781.</mixed-citation><mixed-citation xml:lang="en">Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358(2):152-61. doi: 10.1056/NEJMoa060781.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto YM, Elliott PM, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850-8. doi: 10.1093/eurheartj/ehv727.</mixed-citation><mixed-citation xml:lang="en">Pinto YM, Elliott PM, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850-8. doi: 10.1093/eurheartj/ehv727.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lamounier Junior A, Ferrari F, Max R, et al. Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice. Arq Bras Cardiol. 2019;113(2):274-281. doi: 10.5935/abc.20190144.</mixed-citation><mixed-citation xml:lang="en">Lamounier Junior A, Ferrari F, Max R, et al. Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice. Arq Bras Cardiol. 2019;113(2):274-281. doi: 10.5935/abc.20190144.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Arbustini E, Di Toro A, Giuliani L, et al. Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(20):2485-2506. doi: 10.1016/j.jacc.2018.08.2182.</mixed-citation><mixed-citation xml:lang="en">Arbustini E, Di Toro A, Giuliani L, et al. Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(20):2485-2506. doi: 10.1016/j.jacc.2018.08.2182.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart. 2017;103(19):1543-1552. doi: 10.1136/heartjnl-2016-310391.</mixed-citation><mixed-citation xml:lang="en">Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart. 2017;103(19):1543-1552. doi: 10.1136/heartjnl-2016-310391.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy. Circulation. 2019;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934.</mixed-citation><mixed-citation xml:lang="en">Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy. Circulation. 2019;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ware JS, Li J, Mazaika E, et al. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016;374(3):233-41. doi: 10.1056/NEJMoa1505517.</mixed-citation><mixed-citation xml:lang="en">Ware JS, Li J, Mazaika E, et al. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016;374(3):233-41. doi: 10.1056/NEJMoa1505517.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ware JS, Amor-Salamanca A, Tayal U, et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity. J Am Coll Cardiol. 2018;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.</mixed-citation><mixed-citation xml:lang="en">Ware JS, Amor-Salamanca A, Tayal U, et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity. J Am Coll Cardiol. 2018;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Finocchiaro G, Merlo M, Sheikh N, et al. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail. 2020. doi: 10.1002/ejhf.1815.</mixed-citation><mixed-citation xml:lang="en">Finocchiaro G, Merlo M, Sheikh N, et al. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail. 2020. doi: 10.1002/ejhf.1815.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol. 2011;107(6):927-34. doi: 10.1016/j.amjcard.2010.11.010.</mixed-citation><mixed-citation xml:lang="en">Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol. 2011;107(6):927-34. doi: 10.1016/j.amjcard.2010.11.010.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875-881. doi: 10.1111/jce.12401.</mixed-citation><mixed-citation xml:lang="en">Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875-881. doi: 10.1111/jce.12401.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Nunes MCP, Beaton A, Acquatella H, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018;138(12):e169-e209. doi: 10.1161/CIR.0000000000000599.</mixed-citation><mixed-citation xml:lang="en">Nunes MCP, Beaton A, Acquatella H, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018;138(12):e169-e209. doi: 10.1161/CIR.0000000000000599.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Merlo M, Zaffalon D, Stolfo D, et al. ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance. J Cardiovasc Med (Hagerstown). 2019;20(7):450-458. doi: 10.2459/JCM.0000000000000804.</mixed-citation><mixed-citation xml:lang="en">Merlo M, Zaffalon D, Stolfo D, et al. ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance. J Cardiovasc Med (Hagerstown). 2019;20(7):450-458. doi: 10.2459/JCM.0000000000000804.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Perin F, Rodriguez-Vazquez Del Rey MDM, Carreras-Blesa C, et al. Dilated Cardiomyopathy With Short QT Interval Suggests Primary Carnitine Deficiency. Rev Esp Cardiol (Engl Ed). 2018;71(12):1074-1075. doi: 10.1016/j.rec.2017.09.004.</mixed-citation><mixed-citation xml:lang="en">Perin F, Rodriguez-Vazquez Del Rey MDM, Carreras-Blesa C, et al. Dilated Cardiomyopathy With Short QT Interval Suggests Primary Carnitine Deficiency. Rev Esp Cardiol (Engl Ed). 2018;71(12):1074-1075. doi: 10.1016/j.rec.2017.09.004.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Vergani V, Lazzeroni D, Peretto G. Bridging the gap between hypertrabeculation phenotype, noncompaction phenotype and left ventricular noncompaction cardiomyopathy. J Cardiovasc Med (Hagerstown). 2020;21(3):192-199. doi: 10.2459/JCM.0000000000000924.</mixed-citation><mixed-citation xml:lang="en">Vergani V, Lazzeroni D, Peretto G. Bridging the gap between hypertrabeculation phenotype, noncompaction phenotype and left ventricular noncompaction cardiomyopathy. J Cardiovasc Med (Hagerstown). 2020;21(3):192-199. doi: 10.2459/JCM.0000000000000924.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Weir-McCall JR, Yeap PM, Papagiorcopulo C, et al. Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy? J Am Coll Cardiol. 2016;68(20):2157-2165. doi: 10.1016/j.jacc.2016.08.054.</mixed-citation><mixed-citation xml:lang="en">Weir-McCall JR, Yeap PM, Papagiorcopulo C, et al. Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy? J Am Coll Cardiol. 2016;68(20):2157-2165. doi: 10.1016/j.jacc.2016.08.054.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">van Waning JI, Caliskan K, Hoedemaekers YM, et al. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy. J Am Coll Cardiol. 2018;71(7):711-722. doi: 10.1016/j.jacc.2017.12.019.</mixed-citation><mixed-citation xml:lang="en">van Waning JI, Caliskan K, Hoedemaekers YM, et al. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy. J Am Coll Cardiol. 2018;71(7):711-722. doi: 10.1016/j.jacc.2017.12.019.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">D'Ascenzi F, Pelliccia A, Natali BM, et al. Exercise-induced left-ventricular hypertrabeculation in athlete's heart. Int J Cardiol. 2015;181:320–322. doi: http://dx.doi.org/10.1016/j.ijcard.2014.11.203.</mixed-citation><mixed-citation xml:lang="en">D'Ascenzi F, Pelliccia A, Natali BM, et al. Exercise-induced left-ventricular hypertrabeculation in athlete's heart. Int J Cardiol. 2015;181:320–322. doi: http://dx.doi.org/10.1016/j.ijcard.2014.11.203.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Gati S, Papadakis M, Papamichael ND, et al. Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation. 2014;130(6):475-83. doi: 10.1161/CIRCULATIONAHA.114.008554.</mixed-citation><mixed-citation xml:lang="en">Gati S, Papadakis M, Papamichael ND, et al. Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation. 2014;130(6):475-83. doi: 10.1161/CIRCULATIONAHA.114.008554.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Gati S, Papadakis M, Van Niekerk N, et al. Increased left ventricular trabeculation in individuals with sickle cell anaemia: physiology or pathology? Int J Cardiol. 2013;168(2):1658-60. doi: 10.1016/j.ijcard.2013.03.039.</mixed-citation><mixed-citation xml:lang="en">Gati S, Papadakis M, Van Niekerk N, et al. Increased left ventricular trabeculation in individuals with sickle cell anaemia: physiology or pathology? Int J Cardiol. 2013;168(2):1658-60. doi: 10.1016/j.ijcard.2013.03.039.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Gati S, Chandra N, Bennett RL, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99(7):506. doi: 10.1136/heartjnl- 2012-303418.</mixed-citation><mixed-citation xml:lang="en">Gati S, Chandra N, Bennett RL, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99(7):506. doi: 10.1136/heartjnl- 2012-303418.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
